Immunotec, a Canadian company based in Quebec, launched in 1996 to market nutritional supplements. The company's products draw on glutathione research conducted by Gustavo Bonous in the 1980s. Immunotec went public in 2007, with its shares (IMM:CN) currently trading at 28 cents Canadian.
Charles L. Orr leads Immunotec as CEO, a role he assumed in May 2013. His corporate biography notes he has served as an Immunotec director since 2006. Orr previously held the CEO position at Shaklee, a health and wellness company, from 1993 to 2000. He brings 23 years of direct selling experience, along with extensive leadership in the financial services and computer industries.
Orr replaced Robert Henry, who "departed" on May 13th. A subsequent corporate update from Immunotec in June clarified that Henry was "terminated" on May 10th, not merely departed. The Board had requested Henry's resignation as a director for the corporation and its subsidiaries.
Henry declined to resign. This prompted the Board to approve calling a special meeting of shareholders to remove him from its Board. Immunotec later settled with Henry for $522,000 USD.
A joint statement from Immunotec Inc. and Mr. Robert Henry announced they had "amicably concluded a final settlement" regarding claims from his past involvement with the company. The statement also included mutual appreciation, with the company thanking Henry for his contributions, and Henry expressing appreciation to the company's founders, management, employees, distributors, and customers.
Immunotec's flagship product is Immunocal, developed by Gustavo Bounous. The company states Immunocal holds multiple "method of use" patents, is listed in the Physicians' Desk Reference, and appears in international medical journals. Immunocal is a specially formulated dietary product, built on a pure protein derived from whey.
A unique patented method isolates these specific whey proteins, ensuring they remain in their natural state during processing. Maintaining the integrity of these fragile proteins is critical to the product's function.